Similar to D2/3 receptor studies, we found no significant difference in the variability of DAT availability in the MDD group compared to controls (CVR = 1.09; 95% CI, 0.92–1.28, p = 0.312, Figure 4). Here, SLC6A3 is linked to major depressive disorder.